117 related articles for article (PubMed ID: 12481252)
1. Opposite effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin on morphology and the expression of prostate specific genes in the normal rat prostate.
Xu X; Wu W; Williams V; Khong A; Chen YH; Deng C; Walker AM
Prostate; 2003 Jan; 54(1):25-33. PubMed ID: 12481252
[TBL] [Abstract][Full Text] [Related]
2. Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes beta-casein gene expression in the rat mammary gland.
Kuo CB; Wu W; Xu X; Yang L; Chen C; Coss D; Birdsall B; Nasseri D; Walker AM
Cell Tissue Res; 2002 Sep; 309(3):429-37. PubMed ID: 12195299
[TBL] [Abstract][Full Text] [Related]
3. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
Xu X; Kreye E; Kuo CB; Walker AM
Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059
[TBL] [Abstract][Full Text] [Related]
4. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.
Wu W; Coss D; Lorenson MY; Kuo CB; Xu X; Walker AM
Biochemistry; 2003 Jun; 42(24):7561-70. PubMed ID: 12809512
[TBL] [Abstract][Full Text] [Related]
5. Common and specific effects of the two major forms of prolactin in the rat testis.
Williams VL; DeGuzman A; Dang H; Kawaminami M; Ho TW; Carter DG; Walker AM
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1795-803. PubMed ID: 17911340
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL.
Schroeder MD; Brockman JL; Walker AM; Schuler LA
Endocrinology; 2003 Dec; 144(12):5300-7. PubMed ID: 12970160
[TBL] [Abstract][Full Text] [Related]
7. Both prolactin (PRL) and a molecular mimic of phosphorylated PRL, S179D-PRL, protect the hippocampus of female rats against excitotoxicity.
Morales T; Lorenson M; Walker AM; Ramos E
Neuroscience; 2014 Jan; 258():211-7. PubMed ID: 24252319
[TBL] [Abstract][Full Text] [Related]
8. Intracerebroventricular administration of the prolactin (PRL) receptor antagonist, S179D PRL, disrupts parturition in rats.
Nephew BC; Amico J; Cai HM; Walker AM; Bridges RS
Reproduction; 2007 Jul; 134(1):155-60. PubMed ID: 17641097
[TBL] [Abstract][Full Text] [Related]
9. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
10. S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist.
Bernichtein S; Kinet S; Jeay S; Llovera M; Madern D; Martial JA; Kelly PA; Goffin V
Endocrinology; 2001 Sep; 142(9):3950-63. PubMed ID: 11517174
[TBL] [Abstract][Full Text] [Related]
11. Central infusions of the recombinant human prolactin receptor antagonist, S179D-PRL, delay the onset of maternal behavior in steroid-primed, nulliparous female rats.
Bridges R; Rigero B; Byrnes E; Yang L; Walker A
Endocrinology; 2001 Feb; 142(2):730-9. PubMed ID: 11159845
[TBL] [Abstract][Full Text] [Related]
12. Decidual activin: its role in the apoptotic process and its regulation by prolactin.
Tessier C; Prigent-Tessier A; Bao L; Telleria CM; Ferguson-Gottschall S; Gibori GB; Gu Y; Bowen-Shauver JM; Horseman ND; Gibori G
Biol Reprod; 2003 May; 68(5):1687-94. PubMed ID: 12606360
[TBL] [Abstract][Full Text] [Related]
13. Prolactin-modulated gene expression profiles in pancreatic islets from adult female rats.
Bordin S; Amaral ME; Anhê GF; Delghingaro-Augusto V; Cunha DA; Nicoletti-Carvalho JE; Boschero AC
Mol Cell Endocrinol; 2004 May; 220(1-2):41-50. PubMed ID: 15196698
[TBL] [Abstract][Full Text] [Related]
14. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.
Asirvatham AJ; Schmidt MA; Chaudhary J
Prostate; 2006 Jun; 66(9):921-35. PubMed ID: 16541417
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of sex steroid hormones on the expression of multiple first exons including a novel first exon of prolactin receptor gene in the rat liver.
Tanaka M; Suzuki M; Kawana T; Segawa M; Yoshikawa M; Mori M; Kobayashi M; Nakai N; Saito TR
J Mol Endocrinol; 2005 Jun; 34(3):667-73. PubMed ID: 15956338
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of delayed type hypersensitivity response to Candida albicans produced by a molecular mimic of phosphorylated prolactin.
Guzmán EA; Chen YH; Langowski JL; De Guzman A; Lo HL; Walter B; Muller HK; Walker AM; Owen LB
J Neuroimmunol; 2005 Dec; 170(1-2):31-40. PubMed ID: 16169603
[TBL] [Abstract][Full Text] [Related]
17. Expression and hormone regulation of prolactin receptors in rat dorsal and lateral prostate.
Nevalainen MT; Valve EM; Ingleton PM; Härkönen PL
Endocrinology; 1996 Jul; 137(7):3078-88. PubMed ID: 8770934
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and prolactin regulation of rat dorsal and lateral prostate in organ culture.
Nevalainen MT; Valve EM; Mäkelä SI; Bläuer M; Tuohimaa PJ; Härkönen PL
Endocrinology; 1991 Aug; 129(2):612-22. PubMed ID: 1830268
[TBL] [Abstract][Full Text] [Related]
19. S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells.
Wu W; Ginsburg E; Vonderhaar BK; Walker AM
Cancer Res; 2005 Aug; 65(16):7509-15. PubMed ID: 16103106
[TBL] [Abstract][Full Text] [Related]
20. Different forms of prolactin have opposing effects on the expression of cell cycle regulatory proteins in differentiated mammary epithelial cells.
Wu W; Chen YH; Ueda E; Tan D; Bartolini P; Walker AM
Oncol Res; 2006; 16(2):75-84. PubMed ID: 16898268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
